Transmission of lupus anticoagulant by allogeneic stem cell transplantation
Rev. bras. hematol. hemoter
;
36(4): 287-289, Jul-Aug/2014.
Article
in English
| LILACS
| ID: lil-718397
ABSTRACT
Passive transmission of autoimmune diseases by allogeneic stem cell transplantation is rare and is ascribed to passive transfer of memory B-cells from donor to recipient. We hereby report a case of transmission of an asymptomatic lupus anticoagulant from a sibling donor to a recipient of transplantation for secondary acute myeloid leukemia. On pre-harvest evaluation, the sibling donor with no history of bleeding or thrombosis was found to have a lupus anticoagulant. After engraftment, the recipient was found to have a new prolonged activated partial thromboplastin time and was subsequently shown to have a lupus anticoagulant on Day +73 after stem cell transplantation. The recipient remained well with no evidence of bleeding, thrombosis, or graft-versus-host disease and was on a stable dose of tacrolimus at the time the lupus anticoagulant was detected. There was no other identifiable trigger for the appearance of a lupus anticoagulant...
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Partial Thromboplastin Time
/
Transplantation, Homologous
/
Lupus Coagulation Inhibitor
/
Hematopoietic Stem Cell Transplantation
Type of study:
Prognostic study
Limits:
Aged
/
Humans
/
Male
Language:
English
Journal:
Rev. bras. hematol. hemoter
Journal subject:
Hematology
Year:
2014
Type:
Article
Affiliation country:
United States
Institution/Affiliation country:
Case Western Reserve University/US
Similar
MEDLINE
...
LILACS
LIS